CHARLES RIVER LABORATORIES INTERNATIONAL, INC. Business Acquisition, Contingent Consideration, at Fair Value (Deprecated 2013-01-31)
CHARLES RIVER LABORATORIES INTERNATIONAL, INC. (CRL) had Business Acquisition, Contingent Consideration, at Fair Value (Deprecated 2013-01-31) of $0 as of 2012-12-29, per its 10-Q filed 2013-07-31.
Discontinued › Notes › Business Combinations
us-gaap:BusinessAcquisitionContingentConsiderationAtFairValue · last filed 2013-07-31
- 2012-12-29: Business Acquisition, Contingent Consideration, at Fair Value (Deprecated 2013-01-31) $0.00.
- 2011-06-25: Business Acquisition, Contingent Consideration, at Fair Value (Deprecated 2013-01-31) $4.31M.
| Period end | Business Acquisition, Contingent Consideration, at Fair Value (Deprecated 2013-01-31) |
|---|---|
| 2012-12-29 | $0.00 10-Q · filed 2013-07-31 |
| 2011-06-25 | $4.31M 10-Q · filed 2011-08-03 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Medpace Holdings, Inc. (MEDP) | United States | $17.316B | 30.09 |
| INCYTE CORP (INCY) | United States | $24.855B | 13.14 |
| Absci Corp (ABSI) | United States | $1.775B | -14.92 |
| OmniAb, Inc. (OABI) | United States | $0.698B | -8.05 |
| NRC HEALTH (NRC) | United States | $0.450B | 42.50 |
| MAXCYTE, INC. (MXCT) | United States | $0.124B | -3.68 |
| bioAffinity Technologies, Inc. (BIAF) | United States | $0.063B | |
| OneMedNet Corp (ONMD) | $0.042B | ||
| iSpecimen Inc. (ISPC) | United States | $0.003B | |
| FOXO TECHNOLOGIES INC. (FOXO) | United States | $0.000B | -277.71 |